More serious risks include pancreatitis, gallbladder disease, acute kidney injury (particularly with dehydration), hypoglycemia (when combined with insulin or sulfonylureas), and thyroid C-cell tumors in animal studies
Patients receiving GLP-1 agonists experienced greater weight loss ( 3.81 kg
18 : 275278 Curti D, Dagani F, Galmozzi MR, Marzatico F
The findings of the SURMOUNT OSA trial supported this hypothesis, showing a significant improvement in AHI, hypoxic burden and sleep quality with tirzepatide compared to placebo at 52 weeks 38
The timeframe for experiencing menstrual changes varies some women notice differences within the first few months, whilst others see changes only after significant weight loss (typically 5-10% of body weight or more)
By analogy, protein (de)-phosphorylation, albeit thermodynamically favorable, is not controlled by the G for ATP hydrolysis or Atkinson's highly quoted energy charge (Atkinson and Fall, 2009